Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.74% vs -32.87% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -104.45% vs 58.70% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -35.24% vs 438.71% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 100.00% vs -50.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Taiko Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.74% vs -32.87% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -14.90% vs 12.26% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -104.45% vs 58.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -104.45% vs 207.75% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -35.24% vs 438.71% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -79.58% vs 604.55% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 100.00% vs -50.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






